Education
About Us
Working with TipRanks
Follow Us
Janus Living, Inc. Class A (JAN)
:JAN
JAN Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Janus Living, Inc. Class A News
JAN FAQ
What was Janus Living, Inc. Class A’s price range in the past 12 months?
Currently, no data Available
What is Janus Living, Inc. Class A’s market cap?
Currently, no data Available
When is Janus Living, Inc. Class A’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Janus Living, Inc. Class A’s earnings last quarter?
Currently, no data Available
Is Janus Living, Inc. Class A overvalued?
According to Wall Street analysts Janus Living, Inc. Class A’s price is currently Undervalued.
Does Janus Living, Inc. Class A pay dividends?
Janus Living, Inc. Class A does not currently pay dividends.
What is Janus Living, Inc. Class A’s EPS estimate?
Janus Living, Inc. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Janus Living, Inc. Class A have?
Currently, no data Available
What happened to Janus Living, Inc. Class A’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Janus Living, Inc. Class A?
Currently, no hedge funds are holding shares in JAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Janus Living, Inc. Class A
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs; and designs, develops, and sells cellular transceiver modules and associated wireless services. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.